订阅小程序
旧版功能

Subcutaneous Daratumumab in Chinese Patients with Relapsed or Refractory Multiple Myeloma: an Open-Label, Multicenter, Phase 1 Study (MMY1010)

Gang An,Zheng Ge,Hongmei Jing,Jing Liu,Guoping Yang,Ru Feng,Zhongyuan Xu,Ming Qi,Jianping Wang, Juanjuan Song, Wei Zhou, Binbin Sun, Dian Zhu, Xi Chen,Canchan Cui,Lugui Qiu

Blood Science（2024）

引用 0|浏览14
关键词
Chinese,Daratumumab,Multiple myeloma,Pharmacokinetic,Relapse/refractory,Safety,Subcutaneous
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要